Show simple item record

dc.contributor.authorGurleyik, G.
dc.contributor.authorCabioglu, Neslihan
dc.contributor.authorUgurlu, U. M.
dc.contributor.authorCol, C.
dc.contributor.authorBozkurt, B.
dc.contributor.authorUzunkoy, A.
dc.contributor.authorSezgin, E.
dc.contributor.authorSoran, A.
dc.contributor.authorMuslumanoglu, M.
dc.contributor.authorKaranlik, H.
dc.contributor.authorAksaz, E.
dc.contributor.authorUras, C.
dc.contributor.authorOzbas, S.
dc.contributor.authorIgci, A.
dc.contributor.authorCanturk, Z.
dc.contributor.authorUtkan, Z.
dc.contributor.authorOzaslan, C.
dc.contributor.authorEvrensel, T.
dc.contributor.authorOzmen, V.
dc.contributor.authorSoyder, A.
dc.date.accessioned2021-03-04T15:10:54Z
dc.date.available2021-03-04T15:10:54Z
dc.identifier.citationOzmen V., Ozbas S., Karanlik H., Muslumanoglu M., Igci A., Canturk Z., Utkan Z., Ozaslan C., Evrensel T., Uras C., et al., "The importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trial", 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, cilt.30
dc.identifier.otherav_8567ab24-87ed-4650-9b7d-62d0e336e82c
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/90711
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectONKOLOJİ
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectOncology
dc.subjectHealth Sciences
dc.titleThe importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trial
dc.typeBildiri
dc.contributor.departmentMAMER , ,
dc.identifier.volume30
dc.contributor.firstauthorID157498


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record